Oncology Med Upgrades Its OTC Market Tier Status to the "Current Information" Category
06 Marzo 2008 - 8:09AM
Marketwired
PITTSBURGH, PA , a Pittsburgh-based cancer treatment solutions
group, announced today that it has upgraded its OTC market tier
status to the "Current Information" category by making current
information publicly available on the Pink Sheets News Service, in
accordance with the Pink Sheets Guidelines for Providing Adequate
Current Information.
"We have always desired full disclosure so investors can fully
understand our Company and its operations," commented Dr. William
Walker, CEO of Oncology Med. "We have made tremendous progress in
our operations during fiscal year 2007 and we want to continue to
inform the investor community of our future results. This puts our
Company in one of the top OTC market tiers and will help our
Company achieve broader investor interest, increase our respect in
the health care community, increase our ability to raise capital on
better terms in the capital markets and increase our ability to use
our securities as currency for potential accretive acquisitions. We
believe that this is a very important step in the evolution of our
Company as we continue to strive for growth and shareholder
value."
About Oncology Med, Inc.
Oncology Med is a public company engaged in the fulfillment of
services related to the treatment of various cancers. It currently
provides analysis and design of radiation treatment plans in order
for radiation oncologists to administer radiation treatments to
cancer patients. Current services facilitate radiation treatment
programs ranging from external beam radiation to more advanced
radiation treatment technologies.
More information about Oncology Med, Inc. can be found at
www.oncologymed.com.
NOTE: This press release may contain "forward-looking
statements." In some cases, you can identify forward-looking
statements by terminology such as "may," "will," "should," "could,"
"expects," "plans," "intends," "anticipates," "believes,"
"estimates," "predicts," "potential," "continue" or the negative of
such terms and other comparable terminology. These forward-looking
statements include, without limitation, statements about our market
opportunity, our strategies, competition, expected activities and
expenditures as we pursue our business plan, and the adequacy of
our available cash resources. Although we believe that the
expectations reflected in any forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity,
performance or achievements. Actual results may differ materially
from the predictions discussed in these forward-looking statements.
Changes in the circumstances upon which we base our predictions
and/or forward-looking statements could materially affect our
actual results.
For information, please contact: Oncology Med, Inc. Email
Contact
Bellatora (PK) (USOTC:ECGR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Bellatora (PK) (USOTC:ECGR)
Gráfica de Acción Histórica
De May 2023 a May 2024